Deafness, Autosomal Recessive 53: Clinical Trials

1 trial for Deafness, Autosomal Recessive 53, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1

Follow Deafness, Autosomal Recessive 53: new trials by email Literature Review of Deafness, Autosomal Recessive 53 trials Research Report on Deafness, Autosomal Recessive 53

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Intravenous INO-1001 Plus Oral Temozolomide to Evaluate Tolerability, Safety, and Pharmacokinetics in Patients With Melanoma
INO-1001, temozolomide - Melanoma
Phase 1TerminatedGenentech, Inc.392005-10-012009-03-11

Narrower conditions

Melanoma (1)

Broader conditions

Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)  ·  Neoplasms, Germ Cell and Embryonal (1)  ·  Neoplasms, Nerve Tissue (1)  ·  Neuroectodermal Tumors (1)  ·  Neuroendocrine Tumors (1)  ·  Nevi and Melanomas (1)  ·  Skin Diseases (1)  ·  Skin Neoplasms (1)  ·  Skin and Connective Tissue Diseases (1)

Interventions

INO 1001 (1)  ·  Temozolomide (1)

Sponsors

Genentech, Inc. (1)

Top investigators

Jennifer Low, M.D., Ph.D. (1)